1989
DOI: 10.1136/bmj.298.6681.1181-b
|View full text |Cite
|
Sign up to set email alerts
|

Mineralocorticoid deficiency in HIV infection.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1993
1993
2008
2008

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 1 publication
0
2
0
Order By: Relevance
“…According to the recent reports on AIDSpatients with Pneumocystis carinii pneumonia, hyperkalemia is recognized in 44 to 70%of patients who are given Tmp-Smxat high doses (6)(7)(8)(13)(14)(15)(16). This hyperkalemia is also supposed to be due to high-dose Tmp-Smx therapy which causes reduced sodium reabsorption and potassium excretion in the distal tubules.…”
Section: Discussionmentioning
confidence: 99%
“…According to the recent reports on AIDSpatients with Pneumocystis carinii pneumonia, hyperkalemia is recognized in 44 to 70%of patients who are given Tmp-Smxat high doses (6)(7)(8)(13)(14)(15)(16). This hyperkalemia is also supposed to be due to high-dose Tmp-Smx therapy which causes reduced sodium reabsorption and potassium excretion in the distal tubules.…”
Section: Discussionmentioning
confidence: 99%
“…A 40-year-old woman with transplanted lungs developed life threatening hyperkalaemia (6.8 mmol L −" ) during high dose treatment with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia. Trimethoprim has an amiloridelike effect on the distal nephron and may thus induce There have been some reports on hyperkalaemia induced by high dose trimethoprim-sulfamethoxazole (Tmp-Smx) therapy for pneumocystis carinii infection in HIV-infected patients [1][2][3][4]. Hyperkalaemia is not associated with the usual doses of Tmp-Smx, and reports on hyperkalaemia induced by high doses in patients without AIDS are few [5][6][7].…”
mentioning
confidence: 99%